tiprankstipranks
Xvivo Perfusion AB (SE:XVIVO)
:XVIVO
Sweden Market
XVIVO
Xvivo Perfusion AB
RESEARCH TOOLSreports
Want to see SE:XVIVO full AI Analyst Report?

Xvivo Perfusion AB (XVIVO) Stock News & Sentiment

3 Followers
XVIVO’s Heart Preservation Trial Shows Improved One‑Year Outcomes in European Study
Premium
Company Announcements
XVIVO’s Heart Preservation Trial Shows Improved One‑Year Outcomes in European Study
10h ago
XVIVO Perfusion Calls 2026 AGM, Proposes New Board Members and Incentive Plan
Premium
Company Announcements
XVIVO Perfusion Calls 2026 AGM, Proposes New Board Members and Incentive Plan
28d ago
XVIVO Perfusion Updates Board Proposals Ahead of 2026 AGM
Premium
Company Announcements
XVIVO Perfusion Updates Board Proposals Ahead of 2026 AGM
2M ago
XVIVO Perfusion nominates experienced healthcare leaders to strengthen board
Premium
Company Announcements
XVIVO Perfusion nominates experienced healthcare leaders to strengthen board
2M ago
XVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
Premium
Company Announcements
XVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
2M ago
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
Premium
Company Announcements
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
2M ago
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
Premium
Company Announcements
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
3M ago
More SE:XVIVO News >

XVIVO News on the Web

XVIVO’s Heart Preservation Trial Shows Improved One‑Year Outcomes in European Study
TipRanks News
Neutral
Xvivo Perfusion announces publication of one-year results from NIHP2019 trial
TipRanks News
Neutral
XVIVO Perfusion Updates Board Proposals Ahead of 2026 AGM
TipRanks News
Neutral
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
TipRanks News
Neutral
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
TipRanks News
Neutral
XVIPF Earnings this Week: How Will it Perform?
TipRanks News
Neutral
XVIVO Schedules Conference Call for 2025 Year-End Results
TipRanks News
Bearish
XVIVO CEO to Spotlight Organ-Transplant Technology at J.P. Morgan Healthcare Conference
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
SE:XVIVO
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:XVIVO’s Media Buzz Sentiment?
2 articles about SE:XVIVO were published this week. In an average week, 1 articles are published.
    What is SE:XVIVO’s weekly average amount of articles?
    In an average week, 1 articles about SE:XVIVO are published.
      What is SE:XVIVO’s News Sentiment?
      50% of articles about SE:XVIVO were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        ALLOAllogene Therapeutics
        TXTMProText Mobility
        REPLReplimune Group
        RVMDRevolution Medicines
        HVOOpen Orphan Plc
        Showing the stocks with the most bullish news sentiment over the past week